OR9Q2
gene geneOn this page
Summary
OR9Q2 (olfactory receptor family 9 subfamily Q member 2, HGNC:15328) is a protein-coding gene on chromosome 11q12.1, encoding Olfactory receptor 9Q2 (Q8NGE9). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 219957 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 57 total
- MANE Select transcript:
NM_001005283
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15328 |
| Approved symbol | OR9Q2 |
| Name | olfactory receptor family 9 subfamily Q member 2 |
| Location | 11q12.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000186513 |
| Ensembl biotype | protein_coding |
| Entrez | 219957 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000641291
RefSeq mRNA: 1 — MANE Select: NM_001005283
NM_001005283
CCDS: CCDS31544
Canonical transcript exons
ENST00000641291 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003811715 | 58189070 | 58189108 |
| ENSE00003813441 | 58190319 | 58194053 |
Expression profiles
Bgee: expression breadth not_expressed, 0 present calls, max score 42.86.
Top tissues by expression
130 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| colonic epithelium | UBERON:0000397 | 42.86 | silver quality |
| granulocyte | CL:0000094 | 39.81 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 36.27 | gold quality |
| monocyte | CL:0000576 | 36.24 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| leukocyte | CL:0000738 | 36.13 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| apex of heart | UBERON:0002098 | 35.40 | gold quality |
| sural nerve | UBERON:0015488 | 35.10 | gold quality |
| muscle tissue | UBERON:0002385 | 34.41 | gold quality |
| bone marrow | UBERON:0002371 | 32.82 | gold quality |
| lymph node | UBERON:0000029 | 32.21 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| tonsil | UBERON:0002372 | 31.75 | gold quality |
| placenta | UBERON:0001987 | 30.75 | gold quality |
| calcaneal tendon | UBERON:0003701 | 30.74 | gold quality |
| liver | UBERON:0002107 | 30.18 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.95 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| blood | UBERON:0000178 | 29.44 | gold quality |
| urinary bladder | UBERON:0001255 | 29.33 | gold quality |
| vermiform appendix | UBERON:0001154 | 29.21 | gold quality |
| endometrium | UBERON:0001295 | 29.10 | gold quality |
| gall bladder | UBERON:0002110 | 28.51 | gold quality |
| right uterine tube | UBERON:0001302 | 28.44 | gold quality |
| muscle of leg | UBERON:0001383 | 28.29 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 27.98 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.44 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or9q2 | ENSMUSG00000044040 |
| rattus_norvegicus | Or9q2 | ENSRNOG00000013198 |
Paralogs (96): OR5C1 (ENSG00000148215), OR5F1 (ENSG00000149133), OR8K1 (ENSG00000150261), OR5M9 (ENSG00000150269), OR14K1 (ENSG00000153230), OR8J3 (ENSG00000167822), OR5I1 (ENSG00000167825), OR5AU1 (ENSG00000169327), OR9K2 (ENSG00000170605), OR8B12 (ENSG00000170953), OR10H3 (ENSG00000171936), OR8I2 (ENSG00000172154), OR8U1 (ENSG00000172199), OR10V1 (ENSG00000172289), OR5A1 (ENSG00000172320), OR5A2 (ENSG00000172324), OR5B12 (ENSG00000172362), OR5B2 (ENSG00000172365), OR9I1 (ENSG00000172377), OR9G4 (ENSG00000172457), OR5AR1 (ENSG00000172459), OR5AP2 (ENSG00000172464), OR8J1 (ENSG00000172487), OR5B3 (ENSG00000172769), OR10W1 (ENSG00000172772), OR5M3 (ENSG00000174937), OR5J2 (ENSG00000174957), OR10H4 (ENSG00000176231), OR5AN1 (ENSG00000176495), OR14C36 (ENSG00000177174), OR6B3 (ENSG00000178586), OR10Q1 (ENSG00000180475), OR8G2P (ENSG00000181214), OR5AK2 (ENSG00000181273), OR5AK3P (ENSG00000181282), OR5M8 (ENSG00000181371), OR8D4 (ENSG00000181518), OR8H1 (ENSG00000181693), OR8K5 (ENSG00000181752), OR8H3 (ENSG00000181761)
Protein
Protein identifiers
Olfactory receptor 9Q2 — Q8NGE9 (reviewed: Q8NGE9)
All UniProt accessions (2): A0A126GW85, Q8NGE9
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001005283* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (20 total): topological domain 8, transmembrane region 7, chain 1, glycosylation site 1, disulfide bond 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NGE9-F1 | 85.20 | 0.46 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 97–189
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 19 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_ODORANT_BINDING, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION, GOBP_DETECTION_OF_CHEMICAL_STIMULUS
GO Biological Process (4): G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), signal transduction (GO:0007165), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984), odorant binding (GO:0005549)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
370 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR9Q2 | TTPAL | Q9BTX7 | 433 |
| OR9Q2 | KRT82 | Q9NSB4 | 397 |
| OR9Q2 | DRD3 | P35462 | 381 |
| OR9Q2 | MTMR12 | Q9C0I1 | 377 |
| OR9Q2 | R3HDM1 | Q15032 | 358 |
| OR9Q2 | TMCO5A | Q8N6Q1 | 356 |
| OR9Q2 | TMPRSS5 | Q9H3S3 | 354 |
| OR9Q2 | ADAMTS19 | Q8TE59 | 344 |
| OR9Q2 | SPNS3 | Q6ZMD2 | 337 |
| OR9Q2 | GALNT9 | Q9HCQ5 | 327 |
| OR9Q2 | NCOA7 | Q8NI08 | 314 |
| OR9Q2 | HEXIM2 | Q96MH2 | 311 |
| OR9Q2 | MIPOL1 | Q8TD10 | 309 |
| OR9Q2 | PALD1 | Q9ULE6 | 307 |
| OR9Q2 | PPP2R5D | Q14738 | 306 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OR9Q2 | MYH9 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (4): OR9Q2 (Proximity Label-MS), OR9Q2 (Cross-Linking-MS (XL-MS)), OR9Q2 (Cross-Linking-MS (XL-MS)), OR9Q2 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A6NH00, O60403, O95371, O95918, P23266, P23267, P23275, P34984, P47881, P47888, P47893, Q15619, Q5JQS5, Q5TZ20, Q60885, Q60891, Q60894, Q6IEZ7, Q7Z3T1, Q8N628, Q8NG76, Q8NG77, Q8NG97, Q8NGA6, Q8NGC4, Q8NGE3, Q8NGE9, Q8NGQ2, Q8NGQ4, Q8NGR4, Q8NGS0, Q8NGT9, Q8NGX9, Q8NGY1, Q8NGZ6, Q8NH02, Q8NH03, Q8NH04, Q8NHB1, Q8VGD6
Diamond homologs: A6NL26, O95221, P0C617, P0C626, P0C7N1, P0C7N5, P0C7N8, P0DMU2, P37068, P37070, P37071, P37072, Q13606, Q15617, Q15620, Q60880, Q60882, Q60886, Q60893, Q60894, Q60895, Q6IEU7, Q6UXT6, Q7TR96, Q8N0Y5, Q8N127, Q8N146, Q8N162, Q8NG75, Q8NGC0, Q8NGE9, Q8NGF4, Q8NGF7, Q8NGG0, Q8NGG1, Q8NGG2, Q8NGG3, Q8NGG4, Q8NGG5, Q8NGG8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
57 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 56 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
186 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:58191076:G:GT | donor_gain | 0.9800 |
| 11:58191076:G:T | donor_gain | 0.9400 |
| 11:58191079:GTG:G | donor_gain | 0.9200 |
| 11:58191081:G:GA | donor_gain | 0.8300 |
| 11:58191077:A:T | donor_gain | 0.8100 |
| 11:58191080:T:TA | donor_gain | 0.7800 |
| 11:58191376:G:GT | donor_gain | 0.7700 |
| 11:58190930:GGGCT:G | donor_gain | 0.7600 |
| 11:58191158:T:TA | acceptor_gain | 0.7000 |
| 11:58191330:G:GA | donor_gain | 0.6800 |
| 11:58190931:GGCT:G | donor_gain | 0.6700 |
| 11:58190932:GCT:G | donor_gain | 0.6600 |
| 11:58191130:A:AG | donor_gain | 0.6600 |
| 11:58191329:T:TA | donor_gain | 0.6400 |
| 11:58191078:A:AG | donor_gain | 0.6200 |
| 11:58191077:AAGTG:A | donor_loss | 0.6000 |
| 11:58191078:AGTG:A | donor_loss | 0.6000 |
| 11:58191079:GTGGT:G | donor_loss | 0.6000 |
| 11:58191080:TGGTG:T | donor_loss | 0.6000 |
| 11:58191081:GG:G | donor_loss | 0.6000 |
| 11:58191082:GT:G | donor_loss | 0.6000 |
| 11:58191083:T:A | donor_loss | 0.6000 |
| 11:58191246:T:TA | acceptor_gain | 0.5900 |
| 11:58191084:GA:G | donor_loss | 0.5800 |
| 11:58191496:A:AG | acceptor_gain | 0.5800 |
| 11:58191497:G:GG | acceptor_gain | 0.5800 |
| 11:58191075:GGAA:G | donor_gain | 0.5700 |
| 11:58190786:C:G | donor_gain | 0.5600 |
| 11:58191030:C:G | donor_gain | 0.5600 |
| 11:58191159:G:A | acceptor_gain | 0.5500 |
AlphaMissense
2047 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:58191022:T:C | F178L | 0.952 |
| 11:58191024:C:A | F178L | 0.952 |
| 11:58191024:C:G | F178L | 0.952 |
| 11:58190524:T:C | F12L | 0.951 |
| 11:58190526:C:A | F12L | 0.951 |
| 11:58190526:C:G | F12L | 0.951 |
| 11:58190980:T:C | F164L | 0.940 |
| 11:58190982:C:A | F164L | 0.940 |
| 11:58190982:C:G | F164L | 0.940 |
| 11:58190800:T:C | F104L | 0.936 |
| 11:58190802:C:A | F104L | 0.936 |
| 11:58190802:C:G | F104L | 0.936 |
| 11:58190953:A:C | S155R | 0.934 |
| 11:58190955:T:A | S155R | 0.934 |
| 11:58190955:T:G | S155R | 0.934 |
| 11:58190992:T:C | F168L | 0.930 |
| 11:58190994:T:A | F168L | 0.930 |
| 11:58190994:T:G | F168L | 0.930 |
| 11:58191361:A:C | S291R | 0.927 |
| 11:58191363:C:A | S291R | 0.927 |
| 11:58191363:C:G | S291R | 0.927 |
| 11:58191244:T:C | F252L | 0.916 |
| 11:58191246:T:A | F252L | 0.916 |
| 11:58191246:T:G | F252L | 0.916 |
| 11:58191025:T:A | C179S | 0.915 |
| 11:58191026:G:C | C179S | 0.915 |
| 11:58190844:G:A | M118I | 0.910 |
| 11:58190844:G:C | M118I | 0.910 |
| 11:58190844:G:T | M118I | 0.910 |
| 11:58191016:T:C | F176L | 0.910 |
dbSNP variants (sampled 300 via entrez): RS1000709633 (11:58188177 T>C,G), RS1001125231 (11:58191424 A>G), RS1002056361 (11:58194168 C>G), RS1002247973 (11:58189391 T>G), RS1003611074 (11:58192954 T>A,C), RS1003798188 (11:58194064 T>C), RS1003914222 (11:58193773 T>C), RS1004843255 (11:58189231 A>C), RS1005075664 (11:58188743 T>G), RS1005196205 (11:58188874 T>C), RS1005628346 (11:58192686 A>G), RS1005640540 (11:58192582 G>A), RS1005946444 (11:58193495 A>G), RS1006066987 (11:58187543 C>G), RS1006459186 (11:58193768 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006919_4 | Ability to confide in someone | 9.000000e-08 |
| GCST006923_2 | Loneliness | 3.000000e-06 |
| GCST006924_11 | Loneliness (MTAG) | 8.000000e-09 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009592 | social interaction measurement |
| EFO:0007865 | loneliness measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases methylation, increases mutagenesis, affects methylation | 2 |
| bisphenol A | decreases methylation | 1 |
| Air Pollutants | increases expression | 1 |
| Amiodarone | increases expression | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Valproic Acid | increases methylation | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.